Literature DB >> 11123306

Down-regulation of p27Kip1 expression is required for development and function of T cells.

T Tsukiyama1, N Ishida, M Shirane, Y A Minamishima, S Hatakeyama, M Kitagawa, K Nakayama, K Nakayama.   

Abstract

The proliferation of T cells is regulated in a development-dependent manner, but it has been unclear whether proliferation is essential for T cell differentiation. The cyclin-dependent kinase inhibitor p27(Kip1) is abundant throughout development in cells of the T cell lineage, with the exception of late stage CD4(-)CD8(-) thymocytes and activated mature T cells, both of which show a high rate of proliferation. The role of down-regulation of p27(Kip1) expression in T cell development and function has now been investigated by the generation and characterization of three strains of p27 transgenic mice that express the transgene at various levels specifically in the T cell lineage. The numbers of thymocytes at CD4(+)CD8(+), CD4(+)CD8(-), and CD4(-)CD8(+) stages of development as well as those of mature T cells in peripheral lymphoid tissues were reduced in transgenic mice in a manner dependent on the level of p27(Kip1) expression. The development of thymocytes in the transgenic strain in which p27(Kip1) is most abundant (p27-Tg(high) mice) appeared to be blocked at the CD4(-)CD8(-)CD25(+)CD44(low) stage. Peripheral T cells from p27-Tg(high) mice exhibited a reduced ability to proliferate in response to mitogenic stimulation compared with wild-type T cells. Moreover, Ag-induced formation of germinal centers and Ig production were defective in p27-Tg(high) mice. These results suggest that down-regulation of p27(Kip1) expression is required for the development, proliferation, and immunoresponsiveness of T cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11123306     DOI: 10.4049/jimmunol.166.1.304

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Siah1/SIP regulates p27(kip1) stability and cell migration under metabolic stress.

Authors:  Yoshito Nagano; Toru Fukushima; Kazuo Okemoto; Keiichiro Tanaka; David D L Bowtell; Ze'ev Ronai; John C Reed; Shu-ichi Matsuzawa
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

2.  Substituting threonine 187 with alanine in p27Kip1 prevents pituitary tumorigenesis by two-hit loss of Rb1 and enhances humoral immunity in old age.

Authors:  Hongling Zhao; Frederick Bauzon; Enguang Bi; J Jessica Yu; Hao Fu; Zhonglei Lu; Jinhua Cui; Hyungjun Jeon; Xingxing Zang; B Hilda Ye; Liang Zhu
Journal:  J Biol Chem       Date:  2015-01-12       Impact factor: 5.157

3.  Krüppel-like factor 4 (KLF4) directly regulates proliferation in thymocyte development and IL-17 expression during Th17 differentiation.

Authors:  Jie An; Susanne Golech; Jettanong Klaewsongkram; Yongqing Zhang; Kalpana Subedi; Gail E Huston; William H Wood; Robert P Wersto; Kevin G Becker; Susan L Swain; Nanping Weng
Journal:  FASEB J       Date:  2011-06-17       Impact factor: 5.191

4.  The MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B (p27kip1) expression.

Authors:  Zhen-Biao Xia; Relja Popovic; Jing Chen; Catherine Theisler; Tara Stuart; Donna A Santillan; Frank Erfurth; Manuel O Diaz; Nancy J Zeleznik-Le
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-16       Impact factor: 11.205

5.  P27kip1 regulates the cell cycle arrest and survival of activated T lymphocytes in response to interleukin-2 withdrawal.

Authors:  James W Huleatt; James Cresswell; Kim Bottomly; I Nicholas Crispe
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

6.  Thymomegaly, microsplenia, and defective homeostatic proliferation of peripheral lymphocytes in p51-Ets1 isoform-specific null mice.

Authors:  Tsukasa Higuchi; Frank O Bartel; Masahiro Masuya; Takao Deguchi; Kelly W Henderson; Runzhao Li; Robin C Muise-Helmericks; Michael J Kern; Dennis K Watson; Demetri D Spyropoulos
Journal:  Mol Cell Biol       Date:  2007-03-05       Impact factor: 4.272

7.  Regulation of memory CD8 T-cell differentiation by cyclin-dependent kinase inhibitor p27Kip1.

Authors:  Anju Singh; Anna Jatzek; Erin Hemmila Plisch; Rajini Srinivasan; John Svaren; M Suresh
Journal:  Mol Cell Biol       Date:  2010-08-30       Impact factor: 4.272

8.  Expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27Kip1 in hepatocellular carcinoma.

Authors:  Ke-Jun Nan; Zhao Jing; Ling Gong
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

9.  Bone marrow-derived immune cells regulate vascular disease through a p27(Kip1)-dependent mechanism.

Authors:  Manfred Boehm; Michelle Olive; Andrea L True; Martin F Crook; Hong San; Xuan Qu; Elizabeth G Nabel
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

10.  T-cell intrinsic and extrinsic mechanisms of p27Kip1 in the regulation of CD8 T-cell memory.

Authors:  Anna Jatzek; Melba Marie Tejera; Erin H Plisch; Matthew L Fero; M Suresh
Journal:  Immunol Cell Biol       Date:  2012-12-04       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.